Another transcription factor called RUNX3 downregulates c-Myc expression, a key oncogene, through two parallel pathways: directly at the transcriptional level and by attenuating β-catenin/TCFs, downstream of BMPs in CRC cells [134]. The gene discussed is MYC; the disease is colorectal carcinoma.